Nature

Sequential combined treatment with intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation

To study visual and anatomical outcomes of sequenced combined therapy using intravitreal bevacizumab followed by photodynamic therapy (PDT) in eyes with retinal angiomatous proliferation (RAP). Safety ...
Nature

Intravitreal triamcinolone and bevacizumab combination therapy for macular edema due to central retinal vein occlusion refractory to either treatment alone

A review of the literature showed no published cases using a combination of intravitreal triamcinolone and anti-VEGF agents for macular edema due to central retinal vein occlusion (CRVO). We present a ...
Monthly Prescribing Reference

Genentech warns against off-label intravitreal Avastin

Genentech is warning healthcare providers of 36 reports of intraocular adverse events following the off-label intravitreal use of Avastin (bevacizumab) injection. Twenty five of these events occurred ...
Monthly Prescribing Reference

NORSE Eight Trial: Intravitreal Bevacizumab Noninferior to Ranibizumab for Wet AMD

Findings showed the difference in mean change in BCVA at week 12 between ONS-5010 and ranibizumab was -1.009 letters. Topline data were announced from a phase 3 trial demonstrating ONS-5010 ...
Healio

Intravitreal bevacizumab linked to longer ventilation in bronchopulmonary dysplasia

Please provide your email address to receive an email when new articles are posted on . Intravitreal bevacizumab may contribute to the need for longer ventilation support and a reduced chance of ...
Ophthalmology Times

FDA update: Outlook Therapeutics receives CRL for resubmitted ONS-5010 BLA

The FDA issued a CRL for ONS-5010, citing the need for additional confirmatory efficacy evidence despite previous trials ...
The American Journal of Managed Care

Bevacizumab First-line Treatment More Cost-effective in RVO vs Aflibercept

Aflibercept was a less cost-effective treatment for retinal vein occlusion (RVO) compared with bevacizumab, although visual acuity outcomes were similar. Visual acuity outcomes were similar between ...
McKnight's Long-Term Care News

Macular degeneration treatment linked to blindness, FDA advisory says

Injections of the cancer drug Avastin, which is also a treatment for the wet form of age-related macular degeneration, has been linked to reports of blindness. Twelve patients in at least three ...

Outlook Therapeutics Provides Regulatory Update on U.S. Food and Drug Administration Review of ONS-5010/LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD

In the United States, ONS-5010/LYTENAVA™ (bevacizumab-vikg) is investigational. If approved in the United States, ONS-5010/LYTENAVA™, would be the first approved ophthalmic formulation of bevacizumab ...
Healio

Expert explores efficacy of Eylea in weaning patients off wet AMD treatment

Please provide your email address to receive an email when new articles are posted on . Investigators retrospectively analyzed visual and anatomic outcomes of patients who were attempted to be weaned ...
MedPage Today

Pegcetacoplan Injections for Macular Degeneration Linked to Symptomatic Floaters

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Patients with ...